Global Formulation Development Service 麻豆原创 Research Report 2023

Publication ID:

PB504238049

Publication Date:

May 26, 2023

Pages:

102

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Highlights
The global Formulation Development Service market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Formulation Development Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Formulation Development Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Formulation Development Service in Pharmaceutical Industry is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Formulation Development Service include Dalton Pharma Services, Recipharm, Aurigene Pharmaceutical Services, Pharma Mo, Ardena, Intertek, Quay Pharma, Avivia and Metrics Contract Services, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Formulation Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Formulation Development Service.
The Formulation Development Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Formulation Development Service market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Formulation Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Dalton Pharma Services
Recipharm
Aurigene Pharmaceutical Services
Pharma Mo
Ardena
Intertek
Quay Pharma
Avivia
Metrics Contract Services
Syngene
Kemwell Biopharma
Evonik Industries AG
SGS SA
Coriolis Pharma
Doppel Farmaceutici Srl
Nuvisan
Quotient Sciences
Medpharm
PD Partners
Segment by Type
Sterile Dosage Forms
Non-sterile Dosage Forms
Segment by Application
Pharmaceutical Industry
Health Care Products Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Formulation Development Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Formulation Development Service 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sterile Dosage Forms
1.2.3 Non-sterile Dosage Forms
1.3 麻豆原创 by Application
1.3.1 Global Formulation Development Service 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Industry
1.3.3 Health Care Products Industry
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Formulation Development Service 麻豆原创 Perspective (2018-2029)
2.2 Formulation Development Service Growth Trends by Region
2.2.1 Global Formulation Development Service 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Formulation Development Service Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Formulation Development Service Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Formulation Development Service 麻豆原创 Dynamics
2.3.1 Formulation Development Service Industry Trends
2.3.2 Formulation Development Service 麻豆原创 Drivers
2.3.3 Formulation Development Service 麻豆原创 Challenges
2.3.4 Formulation Development Service 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Formulation Development Service Players by Revenue
3.1.1 Global Top Formulation Development Service Players by Revenue (2018-2023)
3.1.2 Global Formulation Development Service Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Formulation Development Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Formulation Development Service Revenue
3.4 Global Formulation Development Service 麻豆原创 Concentration Ratio
3.4.1 Global Formulation Development Service 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Formulation Development Service Revenue in 2022
3.5 Formulation Development Service Key Players Head office and Area Served
3.6 Key Players Formulation Development Service Product Solution and Service
3.7 Date of Enter into Formulation Development Service 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Formulation Development Service Breakdown Data by Type
4.1 Global Formulation Development Service Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Formulation Development Service Forecasted 麻豆原创 Size by Type (2024-2029)
5 Formulation Development Service Breakdown Data by Application
5.1 Global Formulation Development Service Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Formulation Development Service Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Formulation Development Service 麻豆原创 Size (2018-2029)
6.2 North America Formulation Development Service 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Formulation Development Service 麻豆原创 Size by Country (2018-2023)
6.4 North America Formulation Development Service 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Formulation Development Service 麻豆原创 Size (2018-2029)
7.2 Europe Formulation Development Service 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Formulation Development Service 麻豆原创 Size by Country (2018-2023)
7.4 Europe Formulation Development Service 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Formulation Development Service 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Formulation Development Service 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Formulation Development Service 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Formulation Development Service 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Formulation Development Service 麻豆原创 Size (2018-2029)
9.2 Latin America Formulation Development Service 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Formulation Development Service 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Formulation Development Service 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Formulation Development Service 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Formulation Development Service 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Formulation Development Service 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Formulation Development Service 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Dalton Pharma Services
11.1.1 Dalton Pharma Services Company Detail
11.1.2 Dalton Pharma Services Business Overview
11.1.3 Dalton Pharma Services Formulation Development Service Introduction
11.1.4 Dalton Pharma Services Revenue in Formulation Development Service Business (2018-2023)
11.1.5 Dalton Pharma Services Recent Development
11.2 Recipharm
11.2.1 Recipharm Company Detail
11.2.2 Recipharm Business Overview
11.2.3 Recipharm Formulation Development Service Introduction
11.2.4 Recipharm Revenue in Formulation Development Service Business (2018-2023)
11.2.5 Recipharm Recent Development
11.3 Aurigene Pharmaceutical Services
11.3.1 Aurigene Pharmaceutical Services Company Detail
11.3.2 Aurigene Pharmaceutical Services Business Overview
11.3.3 Aurigene Pharmaceutical Services Formulation Development Service Introduction
11.3.4 Aurigene Pharmaceutical Services Revenue in Formulation Development Service Business (2018-2023)
11.3.5 Aurigene Pharmaceutical Services Recent Development
11.4 Pharma Mo
11.4.1 Pharma Mo Company Detail
11.4.2 Pharma Mo Business Overview
11.4.3 Pharma Mo Formulation Development Service Introduction
11.4.4 Pharma Mo Revenue in Formulation Development Service Business (2018-2023)
11.4.5 Pharma Mo Recent Development
11.5 Ardena
11.5.1 Ardena Company Detail
11.5.2 Ardena Business Overview
11.5.3 Ardena Formulation Development Service Introduction
11.5.4 Ardena Revenue in Formulation Development Service Business (2018-2023)
11.5.5 Ardena Recent Development
11.6 Intertek
11.6.1 Intertek Company Detail
11.6.2 Intertek Business Overview
11.6.3 Intertek Formulation Development Service Introduction
11.6.4 Intertek Revenue in Formulation Development Service Business (2018-2023)
11.6.5 Intertek Recent Development
11.7 Quay Pharma
11.7.1 Quay Pharma Company Detail
11.7.2 Quay Pharma Business Overview
11.7.3 Quay Pharma Formulation Development Service Introduction
11.7.4 Quay Pharma Revenue in Formulation Development Service Business (2018-2023)
11.7.5 Quay Pharma Recent Development
11.8 Avivia
11.8.1 Avivia Company Detail
11.8.2 Avivia Business Overview
11.8.3 Avivia Formulation Development Service Introduction
11.8.4 Avivia Revenue in Formulation Development Service Business (2018-2023)
11.8.5 Avivia Recent Development
11.9 Metrics Contract Services
11.9.1 Metrics Contract Services Company Detail
11.9.2 Metrics Contract Services Business Overview
11.9.3 Metrics Contract Services Formulation Development Service Introduction
11.9.4 Metrics Contract Services Revenue in Formulation Development Service Business (2018-2023)
11.9.5 Metrics Contract Services Recent Development
11.10 Syngene
11.10.1 Syngene Company Detail
11.10.2 Syngene Business Overview
11.10.3 Syngene Formulation Development Service Introduction
11.10.4 Syngene Revenue in Formulation Development Service Business (2018-2023)
11.10.5 Syngene Recent Development
11.11 Kemwell Biopharma
11.11.1 Kemwell Biopharma Company Detail
11.11.2 Kemwell Biopharma Business Overview
11.11.3 Kemwell Biopharma Formulation Development Service Introduction
11.11.4 Kemwell Biopharma Revenue in Formulation Development Service Business (2018-2023)
11.11.5 Kemwell Biopharma Recent Development
11.12 Evonik Industries AG
11.12.1 Evonik Industries AG Company Detail
11.12.2 Evonik Industries AG Business Overview
11.12.3 Evonik Industries AG Formulation Development Service Introduction
11.12.4 Evonik Industries AG Revenue in Formulation Development Service Business (2018-2023)
11.12.5 Evonik Industries AG Recent Development
11.13 SGS SA
11.13.1 SGS SA Company Detail
11.13.2 SGS SA Business Overview
11.13.3 SGS SA Formulation Development Service Introduction
11.13.4 SGS SA Revenue in Formulation Development Service Business (2018-2023)
11.13.5 SGS SA Recent Development
11.14 Coriolis Pharma
11.14.1 Coriolis Pharma Company Detail
11.14.2 Coriolis Pharma Business Overview
11.14.3 Coriolis Pharma Formulation Development Service Introduction
11.14.4 Coriolis Pharma Revenue in Formulation Development Service Business (2018-2023)
11.14.5 Coriolis Pharma Recent Development
11.15 Doppel Farmaceutici Srl
11.15.1 Doppel Farmaceutici Srl Company Detail
11.15.2 Doppel Farmaceutici Srl Business Overview
11.15.3 Doppel Farmaceutici Srl Formulation Development Service Introduction
11.15.4 Doppel Farmaceutici Srl Revenue in Formulation Development Service Business (2018-2023)
11.15.5 Doppel Farmaceutici Srl Recent Development
11.16 Nuvisan
11.16.1 Nuvisan Company Detail
11.16.2 Nuvisan Business Overview
11.16.3 Nuvisan Formulation Development Service Introduction
11.16.4 Nuvisan Revenue in Formulation Development Service Business (2018-2023)
11.16.5 Nuvisan Recent Development
11.17 Quotient Sciences
11.17.1 Quotient Sciences Company Detail
11.17.2 Quotient Sciences Business Overview
11.17.3 Quotient Sciences Formulation Development Service Introduction
11.17.4 Quotient Sciences Revenue in Formulation Development Service Business (2018-2023)
11.17.5 Quotient Sciences Recent Development
11.18 Medpharm
11.18.1 Medpharm Company Detail
11.18.2 Medpharm Business Overview
11.18.3 Medpharm Formulation Development Service Introduction
11.18.4 Medpharm Revenue in Formulation Development Service Business (2018-2023)
11.18.5 Medpharm Recent Development
11.19 PD Partners
11.19.1 PD Partners Company Detail
11.19.2 PD Partners Business Overview
11.19.3 PD Partners Formulation Development Service Introduction
11.19.4 PD Partners Revenue in Formulation Development Service Business (2018-2023)
11.19.5 PD Partners Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Dalton Pharma Services
Recipharm
Aurigene Pharmaceutical Services
Pharma Mo
Ardena
Intertek
Quay Pharma
Avivia
Metrics Contract Services
Syngene
Kemwell Biopharma
Evonik Industries AG
SGS SA
Coriolis Pharma
Doppel Farmaceutici Srl
Nuvisan
Quotient Sciences
Medpharm
PD Partners

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.